FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

HELP Committee Advances Biosimilar Bill

The Senate HELP Committee advances legislation sponsored by Sen. Rand Paul that he says will speed approval of biosimilar drugs by eliminating require...

latest-news-card-1
Human Drugs

FDA Cites SGS France Life Sciences Over Bioanalytical Method Validation

A just-posted Form FDA 483 cites SGS France Life Sciences following an 8/2025 inspection, identifying multiple deficiencies involving bioanalytical me...

latest-news-card-1
Biologics

J&J Reports Positive Data From Multiple Myeloma Study

Johnson & Johnson reports promising topline results from the three-arm investigational Phase 3 MonumenTAL-6 study evaluating Tecvayli (teclistamab-cqy...

latest-news-card-1
Marketing

FDA Plan Would Fundamentally Reshape Drug Ads

Two Sheppard attorneys say an FDA proposal to require complete safety and risk information within the content of direct-to-consumer radio and TV ads w...

latest-news-card-1
Medical Devices

FDA, Industry Have MDUFA 6 Agreement in Principle

Attorney Jake Leys says MDUFA 6 reauthorization has moved from negotiations into writing the commitment letter that spells out all that FDA and the me...

latest-news-card-1
Human Drugs

FDA Approves GSK's Jideytro for ROS1-Positive Lung Cancer

FDA approves GSK's Jideytro (zidesamtinib) for certain adults with locally advanced or metastatic ROS1-positive non-small cell lung cancer.

latest-news-card-1
Human Drugs

FDA Cites Cliantha Research on Data Integrity, Quality Unit

FDA investigators cite contract research organization Cliantha Research over data integrity, documentation and clinical research deficiencies followin...

latest-news-card-1
Medical Devices

Petition Urges FDA to Create Pathway for Brain-Computer Interfaces

A citizen petition urges FDA to establish a regulatory framework for implantable brain-computer interfaces designed to expand human sensory perception...

latest-news-card-1
FDA General

FDA May Go Months Without Senate-Confirmed Commissioner: Analysis

An analysis by PharmaVoice says FDA could remain without a Senate-confirmed commissioner for months as political and procedural hurdles complicate eff...

latest-news-card-1
Human Drugs

Diamantas Touts FDA Moves to Boost U.S. Jobs

FDA acting commissioner Kyle Diamantas uses a Fox News editorial to tout agency steps he says are providing new jobs for American workers and protecti...